Toufike Kanouni is the founder of Forward Therapeutics. Forward Therapeutics has raised $50M in total funding. Latest round: Series A.
Toufike Kanouni is the CEO of Forward Therapeutics, a biopharmaceutical company that develops next-generation small molecule therapies for chronic immunological and inflammatory disorders. The company secured a $50 million Series A financing round led by BVF Partners LP, with additional participation from RA Capital Management and OrbiMed. Kanouni co-founded Forward Therapeutics in 2022 and has over 20 years of experience in drug discovery.
Full founder directory · Investor directory · Company funding database · Fundraising library